Revision history of "Effectiveness of vitamin D and metformin as an adjunct to photodynamic therapy and ingenol mebutate in the treatment of non-melanoma skin cancer: a tumor and stromal approach" (Q3167192)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 02:0902:09, 18 August 2022DG Regio talk contribs 77,399 bytes +53,224 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 16:2716:27, 12 October 2021DG Regio talk contribs 12,995 bytes +234 Changed label, description and/or aliases in en: translated_label
  • curprev 16:2716:27, 12 October 2021DG Regio talk contribs 12,761 bytes +2,431 Created claim: summary (P836): Photodynamic therapy (PDT) and ingenol mebutate (IM) are two interesting non-invasive treatments for non-melanoma skin cancer (NMCC) for their effectiveness and ease of use. Taking targets in the tumor microenvironment (MAT) is a combination strategy against tumor cells and stroma, cancer-associated fibroblasts (CAFs). Vitamin D (DV) and metformin could adjuvant treatments with effect on the tumor cell and also on the tumor microenvironment (MAT...

10 October 2021

9 October 2021

8 October 2021